A retrospective, cross-sectional analysis of the dental status and needs of patients taking vascular endothelial growth factor (VEGF) antagonists.

ABSTRACT:

Objectives

There is growing literature related to the dental effects of biologic agents. However, little research has evaluated the dental needs of these patients and limited data is available on patients taking vascular endothelial growth factor (VEGF) antagonists.

Materials and methods

This retrospective cross-sectional study analyzed patients taking VEGF antagonists and their respective dental treatments from 2017 to 2023. Patient demographics, decayed, missing, and filled tooth (DMFT) status, and treatment details were recorded and evaluated descriptively. DMFT from this population was compared to patients taking other biologic agents using t-tests.

Results

Twenty-three patients taking VEGF antagonists received dental treatment. Periodontal treatments were the mos

SUBMITTER: Raucci A 

PROVIDER: S-EPMC11845543 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature